Six startups combine into one dermatology biotech based in Boston and Geneva

A European biotech investor is combining six startups and supercharging their work with a $100 million investment to create new dermatology treatments. The resulting company, called Alys Pharmaceuticals Inc., is based in Boston and Geneva.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks